Specific Diagnostics Announces Results of Two Studies at Hospitals Within AP-HP (Assistance Publique-Hôpitaux de Paris) Evaluating Performance of Reveal Rapid AST System prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
1.
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review.
2.
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention.
3.
Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19).
4.
Shah AS, Wong AW, Hague CJ, et al. A prospective study of 12-week respiratory outcomes in COVID-19–related hospitalisations.
5.
Wei J, Yang H, L
Specific Diagnostics Announces Evaluation Agreement with the French National Reference Centre for Carbapenem-Resistant Enterobacterales (INSERM UMR1184 RESIST unit)
Share Article
Specific Diagnostics today announced it has entered into an evaluation agreement with the NRC (National Referecnce Centre) for Carbapenem-Resistant Enterobacterales (CRE) at Bicêtre Hospital (INSERM UMR1184 RESIST unit), Paris, France. The study is being led by Dr. Laurent Dortet, an Associate Professor at Hôpital Le Kremlin Bicêtre, France, and will evaluate the ability of the Reveal System to detect and characterize resistance of Gram-negative bacteremia samples, particularly those “superbugs” that exhibit resistance to carbapenems, the most powerful antimicrobials available.